Latest AI and machine learning research in other cancers for healthcare professionals.
This work delivers a novel technique to detect brain tumor with the help of enhanced watershed model...
Ovarian cancer is one of the most common gynecological malignancies, ranking third after cervical an...
BACKGROUND: In infrared reflective (IR) marker-based hybrid real-time tumor tracking (RTTT), the int...
Risk evaluation of lymph node metastasis (LNM) for endoscopically resected submucosal invasive (T1) ...
INTRODUCTION: Robot-assisted partial nephrectomy (RAPN) has been increasingly used for renal cell ca...
Advancing diagnostic testing capabilities such as clinical next generation sequencing methods offer ...
OBJECTIVE: Breast cancer is a critical public health issue and a leading cause of cancer-related dea...
TRIAL DESIGN: This was a single-center, unmasked, paralleled, randomized controlled trial.
OBJECTIVE: The purpose of this study was to establish a deep-learning model for segmenting the cervi...
Gastric cancer possesses great histological and molecular diversity, which creates obstacles for rap...
Surgical management for gynecologic malignancies often involves hysterectomy, often constituting the...
BACKGROUND AND OBJECTIVES: Administration of contrast is not desirable for all cases in clinical set...
In the last four years, advances in Deep Learning technology have enabled the inference of selected ...
Three-photon excitation has recently been demonstrated as an effective method to perform intravital ...
Abnormal N6-methyladenosine (m6A) modification is closely associated with the occurrence, developmen...
Gastric cancer is still the fifth most common malignant tumor in the world and has the fourth highes...
PURPOSE: For the image classification problem, the construction of appropriate training data is impo...
Artificial intelligence (AI) can be applied to head and neck imaging to augment image quality and va...
Artificial intelligence has become a popular field of research with goals of integrating it into the...
BACKGROUND: Factors associated with long-term survival in gemcitabine-concurrent proton radiotherapy...